Inventor

BIDLINGMAIER SCOTT

US8 patents

⚠️ This page may combine multiple inventors who share the name “BIDLINGMAIER SCOTT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV CALIFORNIA

4 patents

US10533056B2Jan 14, 2020

Macropinocytosing human anti-CD46 antibodies and targeted cancer therapeutics

UNIV CALIFORNIA3 citations69

US10946106B2Mar 16, 2021

Tumor-specific payload delivery and immune activation using a human antibody targeting a highly specific tumor cell surface antigen

UNIV CALIFORNIA1 citations62

US12325755B2Jun 10, 2025

Macropinocytosing human anti-CD46 antibodies and targeted cancer therapeutics

UNIV CALIFORNIA0 citations59

US11702480B2Jul 18, 2023

Engineered antibodies and uses thereof

UNIV CALIFORNIA0 citations49

IMMUNE RESPONSE CORP INC

2 patents

US6642028B1Nov 4, 2003

Vectors and genes exhibiting increased expression

IMMUNE RESPONSE CORP INC32 citations86

US5744326AApr 28, 1998

Use of viral CIS-acting post-transcriptional regulatory sequences to increase expression of intronless genes containing near-consensus splice sites

IMMUNE RESPONSE CORP INC12 citations69

LIU BIN

1 patent

US9145462B2Sep 29, 2015

Glioblastoma multiforme-reactive antibodies and methods of use thereof

LIU BIN1 citations51

VIRTUOSO BINCO INC

1 patent

US12583932B2Mar 24, 2026

CD38 and ICAM1 antibodies and uses thereof

VIRTUOSO BINCO INC0 citations42